Recent reports [17] have evidenced the unexpected expression of CTLA-4 on tumor cells, thus, we investigated the effects of the human anti-CTLA-4 mAb ipilimumab [22] on a panel of cell lines expressing different levels of this antigen to verify whether it has also a direct anti-tumor cell activity independent from the immune response. Here, CTLA4 is linked to neoplasm.